Given Imaging (GIVN) 17.01 0.00

Given Imaging Ltd
(GIVN) 17.01 0.00

Last Trade:	16.82	Day Range:	16.61 - 17.23
Trade Time:	08:05PM	52wk Range:	13.53 - 22.37
Prev. Close:	16.82	Market Cap:	516.78M
Open:	17.00	Div Yield:	12.84
Volume:	74584	PE:
EPS:	0.00

The Latest On GIVN

Given Imaging Announces Significant New Data on PillCam 5/22/12 11:04am

New Studies Confirm Value of Given Imaging's Advanced Esophageal Diagnostics Products in Diagnosing and Monitoring Esophageal Disorders 5/20/12 5:23pm

Benzinga's Top Pre-Market Gainers 4/5/12 8:22am

Given Imaging Provides Update on PillCam COLON 2 Pivotal Trial Enrollment 1/4/12 8:12am

Given Imaging Files Patent Infringement Lawsuit in Korea Against Intromedic 11/30/11 8:02am

Given Imaging Initiates Pivotal Trial for PillCam COLON 2 in Japan 11/15/11 8:00am

Given Imaging Announces Results From Multiple PillCam COLON Studies Presented at UEGW 2011 10/25/11 6:46am

Given Imaging Announces New Studies Highlighting the Value of ManoScan High Resolution Manometry Testing for Conditions Resulting From Anti-Reflux Surgery 10/25/11 6:30am

Given Imaging Announces Special Meeting of Shareholders 9/27/11 7:01am

Given Imaging Announces Positive Data Published in Gastrointestinal Endoscopy Featuring Second-Generation PillCam COLON 9/26/11 7:07am

Given Imaging Initiates 800-Patient Multi-Center, Pivotal Trial for PillCam COLON 2 6/6/11 7:22am

Given Imaging's PillCam ESO 3 Receives FDA Clearance 5/23/11 7:00am

Given Imaging Announces Significant New Data on PillCam 5/22/12

New Studies Confirm Value of Given Imaging's Advanced Esophageal Diagnostics Products in Diagnosing and Monitoring Esophageal Disorders 5/20/12

Benzinga's Top Pre-Market Gainers 4/5/12

Given Imaging Provides Update on PillCam COLON 2 Pivotal Trial Enrollment 1/4/12

Given Imaging Files Patent Infringement Lawsuit in Korea Against Intromedic 11/30/11

Given Imaging Initiates Pivotal Trial for PillCam COLON 2 in Japan 11/15/11

Given Imaging Announces Results From Multiple PillCam COLON Studies Presented at UEGW 2011 10/25/11

Given Imaging Announces New Studies Highlighting the Value of ManoScan High Resolution Manometry Testing for Conditions Resulting From Anti-Reflux Surgery 10/25/11

Given Imaging Announces Special Meeting of Shareholders 9/27/11

Given Imaging Announces Positive Data Published in Gastrointestinal Endoscopy Featuring Second-Generation PillCam COLON 9/26/11

Given Imaging Initiates 800-Patient Multi-Center, Pivotal Trial for PillCam COLON 2 6/6/11

Given Imaging's PillCam ESO 3 Receives FDA Clearance 5/23/11

Benzinga’s Volume Movers (ISIS, KMGB, CLNE, SYNA, GIVN) 3/31/10

Benzinga’s Volume Movers (AGAM, CTEL, PRGO, GIVN, LOPE) 3/23/10

Benzinga’s Volume Movers (TWLL, CTEL, MNRO, SPMD, GIVN) 3/22/10

Trade GIVN
NOW!

Partner Headlines

Delcath Prices Stock and Warrants - Analyst Blog 5/29/12

MAKO Entangled in Lawsuits - Analyst Blog 5/16/12

Given Imaging 5/8/12

11 Health-Care Names Poised for Gains 4/23/12

Given Product Ok'd for Further Use - Analyst Blog 3/15/11

Press Releases

OrbiMed Launches $222 Million Fund Focused on Israel Life Sciences 4/23/12 Business Wire

Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy 3/12/12 Marketwire

Get the latest GIVN stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Given Imaging Ltd stock price.

Given Imaging Ltd by YCharts

Given Imaging (GIVN) 17.01 0.00

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On GIVN

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social